ARCHIVES

Lasagna Committee Urges Medicare Payment for Experimental Drugs, Care

This article is from The Cancer Letter archive.

Vol. 15 No. 37 | September 29, 1989

Download PDF Visit The Full Archive

Related Articles

Congress Cuts $210 Million From NIH Budget For The Remainder of 2011

April 15, 2011

JRB Wins $3.6 Million Support contract

November 29, 1974

Phase III Trial of ThermoDox Fails to Meet Primary Endpoint

February 22, 2013

NCI Cooperative Group, Cancer Center Trials Listed

August 31, 2007

Interim Analysis of Phase III Data Preferable For Accelerated Approval, FDA’s Pazdur Says

September 6, 2002

Diet Supplements Should Be Held To Scientific Standards, Broder Tells House

August 6, 1993